High Expression of Focal Adhesion Kinase (P125FAK) in Node-Negative Breast Cancer Is Related to Overexpression of HER-2/neu and Activated Akt Kinase but Does Not Predict Outcome

Breast Cancer Research - United Kingdom
doi 10.1186/bcr977
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Overexpression of Cyclo-Oxygenase-2 Is an Independent Predictor of Unfavourable Outcome in Node-Negative Breast Cancer, but Is Not Associated With Protein Kinase B (Akt) and Mitogen-Activated Protein Kinase (ERK1/2, P38) Activation or With Her-2/Neu Signalling Pathways

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Expression of BCL-2 in Node-Negative Breast Cancer Is Associated With Various Prognostic Factors, but Does Not Predict Response to One Course of Perioperative Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
1996English

The Focal Adhesion Kinase (P125FAK) Is Constitutively Active in Human Malignant Melanoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

ALDH1 Expression Is Enriched in Breast Cancers Arising in Young Women but Does Not Predict Outcome

Breast Diseases
OncologySurgery
2014English

HER-2/neu Transcriptionally Activates Jab1 Expression via the AKT/ -Catenin Pathway in Breast Cancer Cells

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Focal Adhesion Kinase (FAK) Activation by Estrogens Involves GPER in Triple-Negative Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

An Aberrant Spliced Transcript of Focal Adhesion Kinase Is Exclusively Expressed in Human Breast Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Immunohistochemical Evaluation of Her-2/Neu Overexpression in Breast Carcinoma in Mosul

Annals of the College of Medicine, Mosul
2008English

Focal Adhesion Kinase (FAK)

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy